Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?

The burden of chronic kidney disease is increasing worldwide, largely due to the increasing global prevalence of diabetes mellitus and hypertension. While renin angiotensin system inhibitors and sodium‐glucose cotransporter two inhibitors are the management cornerstone for reducing kidney and cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Edmund Y. M., Badve, Sunil V., Heerspink, Hiddo J. L., Wong, Muh Geot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100079/
https://www.ncbi.nlm.nih.gov/pubmed/36350038
http://dx.doi.org/10.1111/nep.14130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100079/
https://www.ncbi.nlm.nih.gov/pubmed/36350038
http://dx.doi.org/10.1111/nep.14130

Ejemplares similares